Autolus Therapeutics (AUTL) EBT Margin (2017 - 2026)
Autolus Therapeutics (AUTL) posted EBT Margin of -84.58% for Q2 2026, up 142.53 percentage points from -227.12% a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) EBT Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Autolus Therapeutics was -228.62%, up 518.60 percentage points year-over-year; for FY2025, it was -378.78%, up 1786.57 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of +9315.50 percentage points (FY2020 to FY2025).
- In prior years, Autolus Therapeutics' EBT Margin was -2165.36% in FY2024 (+10108.02 pp), -12273.38% in FY2023 (-9937.42 pp), -2335.96% in FY2022 (+3760.09 pp) and -6096.05% in FY2021 (+3598.23 pp).
- The Q2 2026 figure stands as the highest quarterly EBT Margin in data going back to Q1 2018.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2025, with a gain of 89774.95 percentage points; the weakest was Q3 2021, with a drop of 11550.65 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Autolus Therapeutics | 660.38 Mn | -663.71 Mn | 25.22 Mn | -84.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -84.58% |
| Dec 31, 2025 | -376.78% |
| Sep 30, 2025 | -370.79% |
| Jun 30, 2025 | -227.12% |
| Mar 31, 2025 | -756.36% |
| Dec 31, 2024 | -90,151.72% |
| Mar 31, 2024 | -522.23% |
| Sep 30, 2023 | -11,298.03% |
| Mar 31, 2023 | -3,082.43% |
| Dec 31, 2022 | -194.22% |
| Sep 30, 2022 | -1,805.49% |
| Mar 31, 2022 | -22,342.17% |
| Dec 31, 2021 | -13,412.22% |
| Sep 30, 2021 | -16,684.75% |
| Jun 30, 2021 | -2,403.04% |
| Mar 31, 2021 | -14,494.42% |
| Dec 31, 2020 | -23,746.08% |
| Sep 30, 2020 | -5,134.09% |
| Jun 30, 2020 | -13,333.11% |
| Mar 31, 2020 | -9,931.66% |
API Access
Autolus Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();